nps-568 has been researched along with CKD-MBD in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, NX; Chen, X; Duan, D; Gattone, VH; Henley, C; Martin, D; Moe, SM; Seifert, MF; Sinders, RM | 1 |
| Lindberg, JS | 1 |
| Conklin, RL; Fox, J; Lowe, SH; Nemeth, EF | 1 |
| Fox, J; Furuya, Y; Ishii, H; Nagano, N; Nemeth, EF; Wada, M | 1 |
| Lewin, E; Olgaard, K | 1 |
2 review(s) available for nps-568 and CKD-MBD
| Article | Year |
|---|---|
Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease.
Topics: Aniline Compounds; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phenethylamines; Propylamines; Vitamin D | 2005 |
Prevention of uremic bone disease using calcimimetic compounds.
Topics: Aniline Compounds; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Receptors, Cell Surface; Treatment Outcome; Uremia | 2001 |
3 other study(ies) available for nps-568 and CKD-MBD
| Article | Year |
|---|---|
R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
Topics: Aniline Compounds; Animals; Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Hyperparathyroidism; Male; Minerals; Phenethylamines; Polycystic Kidney, Autosomal Dominant; Propylamines; Rats; Rats, Sprague-Dawley | 2009 |
The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism.
Topics: Aniline Compounds; Animals; Blood Urea Nitrogen; Calcitonin; Calcium; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Male; Organophosphates; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Rats, Sprague-Dawley | 1999 |
Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia.
Topics: Aniline Compounds; Animals; Bone and Bones; Bone Density; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Models, Animal; Doxorubicin; Humans; Hyperparathyroidism, Secondary; Male; Osteomalacia; Parathyroid Hormone; Phenethylamines; Phosphates; Propylamines; Rats; Rats, Sprague-Dawley; Uremia | 2000 |